0.4 ML adalimumab-adaz 100 MG/ML Prefilled Syringe

RxCUI: 2641660
RxNorm name: 0.4 ML adalimumab-adaz 100 MG/ML Prefilled Syringe
Display name: 0.4 ML adalimumab-adaz 100 MG/ML Prefilled Syringe
Full name: 0.4 ML adalimumab-adaz 100 MG/ML Prefilled Syringe
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:38:53

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761071	Hyrimoz	adalimumab-adaz	351(k) Interchangeable	Rx	2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Adalimumab	ADALIMUMAB-ADAZ	Sandoz Inc	3468792f-63ef-4916-8ed1-8214f327d9dd	2025-10-21	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2641660
HYRIMOZ	ADALIMUMAB-ADAZ	Cordavis Limited	3e303a4a-980b-4f2a-9d03-786928758637	2025-10-17	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2641660
HYRIMOZ	ADALIMUMAB-ADAZ	Sandoz Inc	1ac7d061-3380-468c-b077-c05f8dfbc829	2025-10-17	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2641660

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 3 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
3468792f-63ef-4916-8ed1-8214f327d9dd	adalimumab-adaz 40 MG in 0.4 ML Prefilled Syringe [PSN] · 0.4 ML adalimumab-adaz 100 MG/ML Prefilled Syringe [SCD] · adalimumab-adaz 40 MG per 0.4 ML Prefilled Syringe [SY]	3	15	These highlights do not include all the information needed to use ADALIMUMAB-ADAZ safely and effectively. See full prescribing information for ADALIMUMAB-ADAZ. ADALIMUMAB-ADAZ injection, for subcutaneous use Initial U.S. Approval: 2018 This product is HYRIMOZ (adalimumab-adaz). HYRIMOZ (adalimumab-adaz) is biosimilar* to HUMIRA ® (adalimumab).	20251021
1ac7d061-3380-468c-b077-c05f8dfbc829	adalimumab-adaz 40 MG in 0.4 ML Prefilled Syringe [PSN] · 0.4 ML adalimumab-adaz 100 MG/ML Prefilled Syringe [SCD] · adalimumab-adaz 40 MG per 0.4 ML Prefilled Syringe [SY]	3	13	These highlights do not include all the information needed to use HYRIMOZ ® safely and effectively. See full prescribing information for HYRIMOZ. HYRIMOZ (adalimumab-adaz) injection, for subcutaneous use Initial U.S. Approval: 2018 HYRIMOZ (adalimumab-adaz) is biosimilar* to HUMIRA ® (adalimumab)	20251017
3e303a4a-980b-4f2a-9d03-786928758637	adalimumab-adaz 40 MG in 0.4 ML Prefilled Syringe [PSN] · 0.4 ML adalimumab-adaz 100 MG/ML Prefilled Syringe [SCD] · adalimumab-adaz 40 MG per 0.4 ML Prefilled Syringe [SY]	3	7	These highlights do not include all the information needed to use HYRIMOZ ® safely and effectively. See full prescribing information for HYRIMOZ. HYRIMOZ (adalimumab-adaz) injection, for subcutaneous use Initial U.S. Approval: 2018 HYRIMOZ (adalimumab-adaz) is biosimilar* to HUMIRA ® (adalimumab)	20251017